Hyaluronic acid-based hydrogels modulate neuroinflammation and extracellular matrix remodelling in multiple sclerosis: insights from a primary cortical cell model
Source abstract
Abstract
Multiple sclerosis (MS) is the main neurodegenerative disorder among young adults. Cortical involvement in MS has emerged as an important determinant of disease progression. Although inflammation is recognized as a key feature, the mechanisms of cortical pathology are still poorly understood. The critical role of the extracellular matrix (ECM) in the development and homeostasis of the central nervous system (CNS) and hyaluronic acid (HA) in primis has been emphasized. HA synthesis increases during neuroinflammation in the cortex, mostly through hyaluronan synthase 2 (HAS2), generating an ECM scar on demyelinated axons. Here, we aimed to prove the potential role of an external source of HA in CNS inflammation, specifically in a complex in vitro model of neuroinflammation using primary cortical cells (PCC). We engineered and characterized a battery of cross-linked HA-based hydrogels and tested their impact on LPS-triggered inflammation in PCC. The performance of the tested HA scaffolds is promising for their potential use in vivo, exhibiting an appealing anti-inflammatory response. We also studied the effect of the crosslinked HA hydrogels on hyaluronan metabolism and catabolism markers, showing a significant decrease in HAS2 expression, which could have a critical impact on scar generation in demyelinated axons. Finally, we analyzed the effect of the degradation products of the HA constructs, shedding light on the unsolved debate about the potential dual effect of HA-based materials on the CNS depending on their molecular weight. Altogether, our results contribute to baseline knowledge regarding the use of HA-based materials in the context of CNS inflammatory disorders.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Proteoglycans and glycosaminoglycans research · Glycosylation and Glycoproteins Research · Fibroblast Growth Factor Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CÚRAM Research Ireland Center for Medical Devices, University of Galway, Galway H91 W2TY, Ireland
Galway Neuroscience Centre, University of Galway, Galway H91 W2TY, Ireland
Funding
H2020 Marie Skłodowska-Curie Actions · European Regional Development Fund
References (41)
Show source-provided references
1. Glass · Cell · 2010 · 140 · 91810.1016/j.cell.2010.02.016 ↗
2. Matthews · Nat. Rev. Neurol. · 2019 · 15 · 58210.1038/s41582-019-0240-y ↗
3. Milstein · Front. Neurol. · 2019 · 10 · 123210.3389/fneur.2019.01232 ↗
4. Back · Nat. Med. · 2005 · 11 · 96610.1038/nm1279 ↗
5. Crapser · Brain · 2020 · 143 · 26610.1093/brain/awz363 ↗
6. Srivastava · Neurochem. Res. · 2020 · 45 · 67210.1007/s11064-019-02879-1 ↗
7. Kuipers · Proc. Natl. Acad. Sci. U. S. A. · 2016 · 113 · 133910.1073/pnas.1525086113 ↗
8. Safarians · Adv. Healthcare Mater. · 2023 · 12 · 220314310.1002/adhm.202203143 ↗
9. Su · Matrix Biol. · 2019 · 78 · 27210.1016/j.matbio.2018.01.022 ↗
10. Kotla · J. Controlled Release · 2021 · 336 · 59810.1016/j.jconrel.2021.07.002 ↗
11. Perez-Estenaga · ACS Appl. Mater. Interfaces · 2023 · 15 · 5063810.1021/acsami.3c04245 ↗
12. Mathew · Biomaterials · 2013 · 34 · 587210.1016/j.biomaterials.2013.04.010 ↗
13. Nagy · Matrix Biol. · 2019 · 78 · 29210.1016/j.matbio.2018.03.022 ↗
14. Schizas · J. Biomater. Appl. · 2014 · 28 · 82510.1177/0885328213483636 ↗
15. Isa · Sci. Adv. · 2018 · 4 · eaaq059710.1126/sciadv.aaq0597 ↗
16. Martin-Saldana · Matter · 2022 · 5 · 365910.1016/j.matt.2022.09.020 ↗
17. Guimarães · Nat. Rev. Mater. · 2020 · 5 · 35110.1038/s41578-019-0169-1 ↗
18. Kesharwani · J. Drug Delivery Sci. Technol. · 2021 · 66 · 10291410.1016/j.jddst.2021.102914 ↗
19. Zhang · Signal Transduction Targeted Ther. · 2023 · 8 · 26710.1038/s41392-023-01486-5 ↗
20. Goshi · J. Neuroinflammation · 2020 · 17 · 110.1186/s12974-020-01819-z ↗
21. Patil · iScience · 2021 · 24 · 10218210.1016/j.isci.2021.102182 ↗
22. Bagnoli · FASEB J. · 2023 · 37 · e2327210.1096/fj.202301253R ↗
23. Chevalier · Mol. Pharm. · 2024 · 21 · 160910.1021/acs.molpharmaceut.3c00244 ↗
24. J. L.Madrigal and J. R.Caso , The chemokine (CC motif) ligand 2 in neuroinflammation and neurodegeneration , Oxidative Stress and Inflammation in Non-communicable Diseases-Molecular Mechanisms and Perspectives in Therapeutics , 2014 , pp. 209–219
25. Chui · J. Neuroinflammation · 2010 · 7 · 110.1186/1742-2094-7-1 ↗
26. Arisi · J. Neuroinflammation · 2015 · 12 · 110.1186/s12974-015-0347-z ↗
27. Kasper · PLoS One · 2023 · 18 · e028995610.1371/journal.pone.0289956 ↗
28. Katarzyna Greda · J. Neurochem. · 2021 · 157 · 78110.1111/jnc.15279 ↗
29. Itano · J. Biol. Chem. · 1999 · 274 · 2508510.1074/jbc.274.35.25085 ↗
30. Valkonen · BMC Cancer · 2018 · 18 · 110.1186/s12885-018-4569-1 ↗
31. Michael · J. Biol. Chem. · 2011 · 286 · 1952310.1074/jbc.M111.233916 ↗
32. Vigetti · Biochim. Biophys. Acta, Gen. Subj. · 2014 · 1840 · 245210.1016/j.bbagen.2014.02.001 ↗
33. Reinbach · Brain Res. · 2020 · 1745 · 14695010.1016/j.brainres.2020.146950 ↗
34. Sawada · Stem Cell Invest. · 2020 · 7 · 410.21037/sci.2020.02.02 ↗
35. Pibuel · Br. J. Cancer · 2023 · 128 · 1210.1038/s41416-022-01999-w ↗
36. Coulson-Thomas · J. Biol. Chem. · 2016 · 291 · 1993910.1074/jbc.M115.710673 ↗
37. Day · Matrix Biol. · 2019 · 78 · 6010.1016/j.matbio.2018.01.011 ↗
38. Dong · Sci. Rep. · 2016 · 6 · 3692810.1038/srep36928 ↗
39. Zakusilo · Ageing Res. Rev. · 2021 · 72 · 10148510.1016/j.arr.2021.101485 ↗
40. Krejcova · Neuroendocrinol. Lett. · 2009 · 30 · 106
41. Huang · J. Immunol. · 2014 · 192 · 528510.4049/jimmunol.1303060 ↗